Brazil vs Solomon Islands: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Brazil
88.0%
in 2025
Solomon Islands
88.0%
in 2025
Brazil rank
79th
Solomon Islands rank
79th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Brazil
- Solomon Islands
How they compare
Brazil currently reports 88.0% against 88.0% in Solomon Islands, a difference of 0.0%.
The two have swapped places 6 times across 18 shared years of data; in 2008 it was Solomon Islands ahead.
Brazil ranks 79th and Solomon Islands ranks 79th of 192 countries.
Across the 3 decades both report, Brazil averaged higher in 1 and Solomon Islands in 1.
Head to head by decade
| Decade | Brazil | Solomon Islands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 79.9% | 38.8% | 41.1% | Brazil |
| 2020s | 81.2% | 87.5% | 6.3% | Solomon Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Brazil or Solomon Islands?
- Brazil, at 88.0% against 88.0% in Solomon Islands as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Brazil and Solomon Islands?
- 0.0%, with Brazil ahead.
- How many years of comparable data are there for Brazil and Solomon Islands?
- 18 years are reported by both, from 2008 to 2025.
- How do Brazil and Solomon Islands rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Brazil ranks 79th and Solomon Islands ranks 79th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.